Patents
Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676)
06/2000
06/28/2000EP1012144A1 Method for producing (hetero)aromatic hydroxylamines
06/28/2000EP1011677A1 4-aryl-3-aminoquinoline-2-one derivatives as potassium channel modulators
06/28/2000EP1011676A1 Compounds, compositions and method suitable for amelioration of withdrawal syndromes and withdrawal-induced brain damage
06/28/2000EP1011652A1 Novel diarylsulfone non-nucleoside reverse transcriptase inhibitors of human immunodeficiency virus
06/28/2000CN1053907C Process for manufacture of tricyclic compound
06/27/2000US6080790 Selective and potent inhibitors of phosphodiesterase iv and are useful for the prophylaxis and treatment of inflammatory diseases and the alleviation of conditions associated with central nervous malfunction
06/27/2000US6080773 Benzylamine derivatives which are useful in treating psychiatric disorders
06/27/2000US6080767 Substituted n-[(aminoiminomethyl or aminomethyl)phenyl]propyl amides
06/27/2000US6080758 Analgesics, antiinflammatory agents; asthma; allergic rhinitis
06/27/2000US6080757 Treatment of helicobacter (campylobacter) pylori infections; treatment and prevention of peptic ulcers, gastritis, dyspepsia, and gastric cancer
06/27/2000US6080749 For controlling fungus pests
06/22/2000WO2000035905A1 INHIBITORS OF β-LACTAMASES AND USES THEREFOR
06/22/2000WO2000035882A1 1,2,3,4-tetrahydronaphthalenes and their pharmaceutical use
06/21/2000EP1010691A2 Hydrazide derivatives, process for their preparation and pharmaceutical compositions containing them
06/21/2000CN1257489A Substituted benzopyran derivatives for the treatment of inflammation
06/21/2000CN1257482A Quinoline-2-carboxylic acid derivative and its use as excitatory amino acids antagonist
06/21/2000CN1257070A Process for extracting purified isoliensinine and liensinine from plumula nelumbinis
06/21/2000CN1257069A Process for extracting lotucine from plumula nelumbinis
06/21/2000CN1053666C Benzoheterocylic compounds and process for preparing medicated salt thereof
06/20/2000US6077851 Quinoline derivatives
06/20/2000US6077850 Useful for treating cyclooxygenase-2 mediated disorders, such as inflammation and inflammation-related disorders
06/17/2000CA2292246A1 New hydrazide derivatives, the procedure for preparing them and the pharmaceutical formulations that contain them
06/15/2000WO2000034268A1 Thiourea inhibitors of herpes viruses
06/15/2000WO2000034265A2 Quinoline-indole antimicrobial agents
06/15/2000WO2000034260A2 Alpha-methylbenzyl-containing thiourea inhibitors of herpes viruses containing a phenylenediamine group
06/15/2000WO2000034245A2 Crystalline form of benzoquinoline-3-one derivatve as inhibitor of 5-alpha reductase
06/15/2000WO2000034244A1 3-substituted-4-arylquinolin-2-one derivatives as potassium channel modulators
06/15/2000WO2000034237A2 Acetamide and substituted acetamide-containing thiourea inhibitors of herpes viruses
06/15/2000CA2354022A1 Crystalline form of benzoquinoline-3-one derivatve as inhibitor of 5-alpha reductase
06/15/2000CA2350996A1 Thiourea inhibitors of herpes viruses
06/15/2000CA2350899A1 Acetamide and substituted acetamide-containing thiourea inhibitors of herpes viruses
06/15/2000CA2350833A1 Alpha-methylbenzyl-containing thiourea inhibitors of herpes viruses containing a phenylenediamine group
06/14/2000EP1008346A1 NF-$g(k)B INHIBITORS CONTAINING AS THE ACTIVE INGREDIENT PHENYLMETHYL BENZOQUINONE
06/14/2000EP1007514A1 Heterocyclic ketones as npy y5 antagonists
06/14/2000EP0777645B1 Oxime ethers and their use as pesticides
06/13/2000US6075148 Carbamates and crop protection agents containing them
06/13/2000US6075030 Fungicidal mixture
06/13/2000CA2014062C Pyridine derivatives
06/08/2000WO2000032717A1 Electroluminescent quinolates
06/08/2000WO2000032576A1 Method for preparing 4-hydroquinolines and/or tautomeric compounds
06/08/2000WO2000032196A2 Inhibitors of multidrug transporters
06/08/2000CA2353557A1 Inhibitors of multidrug transporters
06/08/2000CA2352884A1 Electroluminescent quinolates
06/07/2000EP1005458A1 Carbostyril derivatives for inhibiting skin erythema and/or skin pigmentation
06/07/2000EP1005446A1 N-aroylphenylalanine derivatives
06/07/2000EP1005445A1 N-alkanoylphenylalanine derivatives
06/07/2000EP1005356A1 Novel antibacterial agents
06/07/2000CN1255853A Medical compsns. against helicobacter pylori
06/07/2000CN1255493A Novel dihydro and tetrahydro chinoline compounds, its prepn. method and medicinal compsns.
06/07/2000CN1053189C Pyridazino qujinoline compounds
06/07/2000CN1053182C Novel 9-amino-7-substituted-6-demethyl-6-deoxytetracyclines, its prepn. process and compsns. thereof
06/06/2000US6071925 Antidepressants, anticonvulsants or antianxiety agents, also for treatment of memory loss in alzheimer's disease
06/06/2000US6071906 Inhibits or modulates the inducible isoform of nitric oxide synthase over the the constitutive isoforms; antiarthritic, -diabetic, ischemic, thrombosis agents; cardiovascular disorders; toxic shock syndrome; autoimmune diseases
06/06/2000US6071895 Polar-substituted hydrocarbons
06/02/2000WO2000031077A1 Semi-hydrochloride of 8-cyan-1- cyclopropyl -7-(1s,6s-2 ,8-diazabicyclo [4.3.0]nonan -8-yl)-6- fluoro-1, 4-dihydro -4-oxo-3- quinoline carboxylic acid
06/02/2000WO2000031074A2 Indole derivatives and their use as serotonin receptor ligands
06/02/2000WO2000031062A1 Cycloalkyl-substituted aminomethylpyrrolidine derivatives
06/02/2000WO2000031051A1 Quinoline and quinoxaline compounds as pdgf-receptor and/or lck tyrosine kinase inhibitors
06/02/2000WO2000031050A1 Quinoline and quinoxaline compounds
06/02/2000WO2000031049A1 Quinoline and quinoxaline compounds as pdgf-r and/or lck tyrosine kinase inhibitors
06/02/2000WO2000031038A1 Quinoline derivatives as nk-2 and nk-3 receptor ligands
06/02/2000WO2000031037A1 Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists
06/02/2000WO2000031036A1 Novel naphthalene derivatives
06/02/2000CA2352584A1 Quinoline and quinoxaline compounds
06/02/2000CA2352583A1 Quinoline and quinoxaline compounds as pdgf-r and/or lck tyrosine kinase inhibitors
06/02/2000CA2352261A1 Quinoline and quinoxaline compounds as pdgf-receptor and/or lck tyrosine kinase inhibitors
06/02/2000CA2351865A1 Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists
06/02/2000CA2351526A1 Indole derivatives and their use as serotonin receptor ligands
06/02/2000CA2351497A1 Cycloalkyl-substituted aminomethylpyrrolidine derivative
05/2000
05/31/2000EP1004582A2 Pyridazino quinoline compounds
05/31/2000EP1003737A1 Phenyl urea and phenyl thiourea derivatives as hfgan72 antagonists
05/31/2000EP1003724A1 Substituted quinoline derivatives with antiviral action
05/31/2000EP1003719A2 Microbicidal n-sulfonylglycin alkynyloxyphenemethyl amide derivatives
05/31/2000EP1003541A1 Inhibitors of hiv reverse transcriptase
05/31/2000EP1003540A1 $g(b)2-ADRENERGIC RECEPTOR AGONISTS
05/31/2000EP0633775B1 Compounds useful for treating inflammatory diseases and for inhibiting production of tumor necrosis factor
05/31/2000DE19854357A1 Semi-Hydrochlorid von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo/4.3.0/ -nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure Semi-hydrochloride of 8-cyano-1-cyclopropyl-7- (1S, 6S-2,8-diazabicyclo / 4.3.0 / nonan-8-yl) -6-fluoro-1,4-dihydro-4-oxo -3-quinolinecarboxylic acid
05/31/2000CN1255119A Protease inhibitors
05/31/2000CN1052984C New erythromycin derivative and its preparing process and application in medicine
05/30/2000US6069254 Carboxamide derivatives of piperidine for the treatment of thrombosis disorders
05/30/2000US6069151 Controlling tumor necrosis factor
05/30/2000US6069148 Cycloalkano-pyridines
05/30/2000US6069144 N-heterocyclic compounds, intermediate products used to prepare them, agents containing them and their use in antifungal applications
05/30/2000US6069114 Herbicides for selectively controlling broad-leaved weeds and grass weeds in crops of useful plants
05/30/2000CA1341009C Intermediates for preparing 4-oxyquinoline-3-carboxylic acid derivatives
05/30/2000CA1341008C A - unsaturated amines, their production and use
05/25/2000WO2000029403A1 Novel pyrimidine derivatives and processes for the preparation thereof
05/25/2000WO2000029379A1 1-aminoethylquinoline derivatives for treating urinary incontinence
05/25/2000CA2351644A1 Pyrimidine derivatives and processes for the preparation thereof
05/24/2000EP1001959A1 Method for producing bidentate monoalkyl metal complexes
05/24/2000EP1001946A1 QUINOLINE AND QUINOXALINE COMPOUNDS WHICH INHIBIT PLATELET-DERIVED GROWTH FACTOR AND/OR p56?1ck TYROSINE KINASES
05/24/2000EP1001945A1 QUINOLINE AND QUINOXALINE COMPOUNDS WHICH INHIBIT PLATELET-DERIVED GROWTH FACTOR AND/OR p56?lck TYROSINE KINASES
05/24/2000EP1001927A2 Novel polyamine analogues as therapeutic and diagnostic agents
05/24/2000EP1001774A1 Use of phospholamban inhibitors to increasing coronary flow
05/24/2000EP1001686A1 Dehydration plant
05/24/2000EP0797386B1 Fungicidal mixture
05/24/2000CN1254337A N-hydroxy 4-sulfonyl butyramide compounds
05/23/2000US6066756 Phenylacetic acid derivatives, preparation thereof and intermediates therefor, and compositions containing them
05/23/2000US6066740 From thiourea intermediate; for treatment of respiratory disorders, ocular disorders, gastrointestinal disorders, nasal decongestion, hypertension, migraine, disorders associated with sympathetic nervous system activity, and substance abuse
05/23/2000US6066730 Boronic ester and acid compounds, synthesis and uses